{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:08:08Z","timestamp":1744171688078,"version":"3.40.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00228-021-03133-w","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T20:21:57Z","timestamp":1620073317000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-2160","authenticated-orcid":false,"given":"Diego Mac\u00edas","family":"Saint-Gerons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Tabar\u00e9s-Seisdedos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"3133_CR1","doi-asserted-by":"crossref","unstructured":"Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, et al (2021) Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. N Engl J Med 384(6):497\u2013511","DOI":"10.1056\/NEJMoa2023184"},{"key":"3133_CR2","unstructured":"Food and Drug Administration (FDA) (2020) Fact sheet for health care providers emergency use authorization (EUA) of chloroquine phosphate supplied from the strategic national stockpile for treatment of Covid-19 in certain hospitalized patients: https:\/\/www.fda.gov\/media\/136535\/download (accessed April, 2020)."},{"key":"3133_CR3","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 105949.","DOI":"10.1101\/2020.03.16.20037135"},{"issue":"369","key":"3133_CR4","doi-asserted-by":"publisher","first-page":"m1432","DOI":"10.1136\/bmj.m1432","volume":"8","author":"RE Ferner","year":"2020","unstructured":"Ferner RE, Aronson JK (2020) Chloroquine and hydroxychloroquine in Covid-19. BMJ 8(369):m1432","journal-title":"BMJ"},{"key":"3133_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40545-020-00244-0","volume":"13","author":"JA Singh","year":"2020","unstructured":"Singh JA, Ravinetto R (2020) COVID-19 therapeutics: How to sow confusion and break public trust during international public health emergencies. J Pharm Policy Pract 13:47","journal-title":"J Pharm Policy Pract"},{"key":"3133_CR6","doi-asserted-by":"publisher","unstructured":"Juurlink DN (2020) Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ. 2020 Apr 8. pii: cmaj.200528.\u00a0https:\/\/doi.org\/10.1503\/cmaj.200528.","DOI":"10.1503\/cmaj.200528"},{"issue":"1","key":"3133_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/europace\/eut214","volume":"16","author":"G Sarganas","year":"2014","unstructured":"Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W et al (2014) Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace 16(1):101\u2013108","journal-title":"Europace"},{"issue":"2","key":"3133_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1517\/14740338.2015.989210","volume":"14","author":"ZK Lu","year":"2015","unstructured":"Lu ZK, Yuan J, Li M, Sutton SS, Rao GA, Jacob S et al (2015) Cardiac risks associated with antibiotics: Azithromycin and levofloxacin. Expert Opin Drug Saf 14(2):295\u2013303","journal-title":"Expert Opin Drug Saf"},{"key":"3133_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","volume":"7","author":"NJ White","year":"2007","unstructured":"White NJ (2007) Cardiotoxicity of antimalarial drugs. Lancet 7:549\u2013558","journal-title":"Lancet"},{"issue":"10","key":"3133_CR10","doi-asserted-by":"publisher","first-page":"e0164309","DOI":"10.1371\/journal.pone.0164309","volume":"11","author":"S Sasaoka","year":"2016","unstructured":"Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y et al (2016) Time-to-onset analysis of drug-induced long QT syndrome based on a spontaneous reporting system for adverse drug events. PLoS ONE 11(10):e0164309","journal-title":"PLoS ONE"},{"issue":"8","key":"3133_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13(8):519\u2013523","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3133_CR12","doi-asserted-by":"crossref","unstructured":"Mac\u00edas Saint-Gerons D, Castro JL (2019) Amyotrophic lateral sclerosis associated with statins. A disproportionality analysis of the WHO Program for International Drug Monitoring database (VigiBase). Eur J Clin Pharmacol. 75(4):587\u2013589.","DOI":"10.1007\/s00228-018-2587-1"},{"issue":"2","key":"3133_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","volume":"12","author":"LX Cubeddu","year":"2016","unstructured":"Cubeddu LX (2016) Drug-induced inhibition and trafficking disruption of ion channels: Pathogenesis of QT abnormalities and drug-induced fatal arrhythmias. Curr Cardiol Rev 12(2):141\u2013154","journal-title":"Curr Cardiol Rev"},{"key":"3133_CR14","unstructured":"World Health Organization (WHO) (2017) The cardiotoxicity of antimalarials. Malaria Policy Advisory Committee Meeting. 22 Mar, 2017. https:\/\/www.who.int\/malaria\/mpac\/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf (accessed April, 2020)."},{"issue":"3","key":"3133_CR15","doi-asserted-by":"publisher","first-page":"e00309","DOI":"10.1002\/prp2.309","volume":"5","author":"AF Schlit","year":"2017","unstructured":"Schlit AF, Delaunois A, Colomar A, Claudio B, Cariolato L, Boev R et al (2017) Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: Re-evaluation of an established drug. Pharmacol Res Perspect 5(3):e00309","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"3133_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/11531850-000000000-00000","volume":"33","author":"E Poluzzi","year":"2010","unstructured":"Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F (2010) Antimicrobials and the risk of torsades de pointes: The contribution from data mining of the US FDA Adverse Event Reporting System. Drug Saf 33(4):303\u2013314","journal-title":"Drug Saf"},{"issue":"1","key":"3133_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/01.ccm.0000528903.23911.aa","volume":"46","author":"MV Berkel","year":"2018","unstructured":"Berkel MV, Taylor A (2018) A rare case of hydroxychloroquine toxicity successfully treated with intralipid emulsion. Therapy Critical Care Medicine 46(1):431","journal-title":"Therapy Critical Care Medicine"},{"issue":"1","key":"3133_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12012-014-9274-y","volume":"15","author":"G Cocco","year":"2015","unstructured":"Cocco G, Jerie P (2015) Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: An unexpected dangerous interaction. Cardiovasc Toxicol 15(1):104\u2013106","journal-title":"Cardiovasc Toxicol"},{"issue":"7","key":"3133_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2016.2065","volume":"176","author":"JB Cole","year":"2016","unstructured":"Cole JB, Stellpflug SJ, Smith SW (2016) Refractory hypotension and \u201cventricular fibrillation\u201d with large U waves after overdose. JAMA Intern Med 176(7):1007\u20131009","journal-title":"JAMA Intern Med"},{"issue":"9","key":"3133_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/clc.20945","volume":"34","author":"GC Digby","year":"2011","unstructured":"Digby GC, P\u00e9rez Riera AR, Barbosa Barros R, Simpson CS, Redfearn DP, Methot M et al (2011) Acquired long QT interval: A case series of multifactorial QT prolongation. Clin Cardiol 34(9):577\u2013582","journal-title":"Clin Cardiol"},{"issue":"11","key":"3133_CR21","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/S0735-1097(17)35729-7","volume":"69","author":"I Ndukwu","year":"2017","unstructured":"Ndukwu I, Ghahramani M (2017) Hydroxychloroquine overdose presenting as acquired QT interval prolongation and torsade de pointes. J Am Coll Cardiol 69(11):2340","journal-title":"J Am Coll Cardiol"},{"key":"3133_CR22","doi-asserted-by":"crossref","unstructured":"Newton-Cheh C, Lin AE, Baggish AL, Wang H (2011) Case records of the Massachusetts General Hospital. Case 11\u20132011. A 47-year-old man with systemic lupus erythematosus and heart failure. N Engl J Med. 364(15):1450\u201360.","DOI":"10.1056\/NEJMcpc1011319"},{"issue":"2 Suppl. 1","key":"3133_CR23","first-page":"S533","volume":"31","author":"M Park","year":"2016","unstructured":"Park M, Nguyen V, Debord J (2016) A twist of fate. J Gen Intern Med 31(2 Suppl. 1):S533\u2013S534","journal-title":"J Gen Intern Med"},{"issue":"10","key":"3133_CR24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11606-016-3738-7","volume":"31","author":"ET Sheehan","year":"2016","unstructured":"Sheehan ET, Frizzell JD, Gabaldon J, West MB (2016) Quinine and the ABCs of long QT: A patient\u2019s misfortune with arthritis, (alcoholic) beverages, and cramps. J Gen Intern Med 31(10):1254\u20131257","journal-title":"J Gen Intern Med"},{"issue":"7","key":"3133_CR25","first-page":"652","volume":"51","author":"S Stellpflug","year":"2013","unstructured":"Stellpflug S, Floan A, Lee S, Cole J (2013) Hydroxychloroquine overdose treated successfully with intravenous fat emulsion. Clin Toxicol 51(7):652","journal-title":"Clin Toxicol"},{"issue":"2","key":"3133_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/08923973.2013.766801","volume":"35","author":"A Vereckei","year":"2013","unstructured":"Vereckei A, Fazakas A, Balo T, Fekete B, Molnar MJ, Karadi I (2013) Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement. Immunopharmacol Immunotoxicol 35(2):304\u2013306","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"3133_CR27","first-page":"34","volume":"3","author":"P Yazdan-Ashoori","year":"2012","unstructured":"Yazdan-Ashoori P, Digby G, Baranchuka A (2012) Failure to treat torsades de pointes. Cardiol Res 3(1):34\u201336","journal-title":"Cardiol Res"},{"issue":"2","key":"3133_CR28","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1097\/MJT.0000000000000451","volume":"25","author":"LR Murphy","year":"2018","unstructured":"Murphy LR, Maskell KF, Kmiecik KJ, Shaffer BM (2018) Intravenous lipid emulsion use for severe hydroxychloroquine toxicity. Am J Ther 25(2):e273\u2013e275","journal-title":"Am J Ther"},{"key":"3133_CR29","doi-asserted-by":"crossref","unstructured":"Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al (2020) Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(9):1036\u20131041","DOI":"10.1001\/jamacardio.2020.1834"},{"issue":"7","key":"3133_CR30","doi-asserted-by":"publisher","first-page":"e236009","DOI":"10.1136\/bcr-2020-236009","volume":"13","author":"R Masson","year":"2020","unstructured":"Masson R, Bakhshi H, Haddad TM (2020) Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity. BMJ Case Rep 13(7):e236009","journal-title":"BMJ Case Rep"},{"issue":"6","key":"3133_CR31","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1177\/1078155220904152","volume":"26","author":"DH Lee","year":"2020","unstructured":"Lee DH, Armanious M, Huang J, Jeong D, Druta M, Fradley MG (2020) Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge. J Oncol Pharm Pract 26(6):1544\u20131548","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"3133_CR32","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","volume":"17","author":"E Chorin","year":"2020","unstructured":"Chorin E, Wadhwani L, Magnani S, Dai M, Shulman E, Nadeau-Routhier C et al (2020) QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin. Heart Rhythm 17(9):1425\u20131433","journal-title":"Heart Rhythm"},{"issue":"10","key":"3133_CR33","doi-asserted-by":"publisher","first-page":"e008841","DOI":"10.1161\/CIRCEP.120.008841","volume":"13","author":"JP Hummel","year":"2020","unstructured":"Hummel JP, Maraj I, Taoutel R, Chamoun R, Workman VK, Tran L et al (2020) Temporal trends in arrhythmogenicity related to treatment of COVID-19 infection. Circ Arrhythm Electrophysiol 13(10):e008841","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"3133_CR34","doi-asserted-by":"publisher","first-page":"e008937","DOI":"10.1161\/CIRCEP.120.008937","volume":"13","author":"M Saleh","year":"2020","unstructured":"Saleh M, Gabriels J, Chang D, Fishbein J, Qiu M, Mountantonakis SE et al (2020) Safely administering potential QTc prolonging therapy across a large health care system in the COVID-19 era. Circ Arrhythm Electrophysiol 13(11):e008937","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"3133_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40119-020-00201-7","volume":"9","author":"HD Huang","year":"2020","unstructured":"Huang HD, Jneid H, Aziz M, Ravi V, Sharma PS, Larsen T et al (2020) Safety and effectiveness of hydroxychloroquine and azithromycin combination therapy for treatment of hospitalized patients with COVID-19: A propensity-matched study. Cardiol Ther 9(2):523\u2013534","journal-title":"Cardiol Ther"},{"issue":"2","key":"3133_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ccep.2016.02.009","volume":"8","author":"M McCauley","year":"2016","unstructured":"McCauley M, Vallabhajosyula S, Darbar D (2016) Proarrhythmic and torsadogenic effects of potassium channel blockers in patients. Card Electrophysiol Clin 8(2):481\u2013493","journal-title":"Card Electrophysiol Clin"},{"issue":"1","key":"3133_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2048872612471215","volume":"2","author":"E Joyce","year":"2013","unstructured":"Joyce E, Fabre A, Mahon N (2013) Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: Key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care 2(1):77\u201383","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"13","key":"3133_CR38","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","volume":"125","author":"AJ Sauer","year":"2012","unstructured":"Sauer AJ, Newton-Cheh C (2012) Clinical and genetic determinants of torsade de pointes risk. Circulation 125(13):1684\u20131694","journal-title":"Circulation"},{"issue":"12","key":"3133_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/2045125317721662","volume":"7","author":"AD Meid","year":"2017","unstructured":"Meid AD, Bighelli I, M\u00e4chler S, Mikus G, Carr\u00e0 G, Castellazzi M et al (2017) Combinations of QTc-prolonging drugs: Towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature. Ther Adv Psychopharmacol 7(12):251\u2013264","journal-title":"Ther Adv Psychopharmacol"},{"key":"3133_CR40","doi-asserted-by":"publisher","unstructured":"Wu CI, Postema PG, Arbelo E, Behr ER, Bezzina CR, Napolitano C, et al (2020) SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes. Heart Rhythm. 2020 Mar 31. pii: S1547\u20135271(20)30285-X. https:\/\/doi.org\/10.1016\/j.hrthm.2020.03.024. [Epub ahead of print].","DOI":"10.1016\/j.hrthm.2020.03.024"},{"issue":"3","key":"3133_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Moroni G (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf 16(3):411\u2013419","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"3133_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Ben-Zvi I, Kivity LP, Shoenfeld Y (2012) Hydroxychloroquine: From malaria to autoimmunity. Clin Rev Allergy Immunol 42(2):145\u2013153","journal-title":"Clin Rev Allergy Immunol"},{"key":"3133_CR43","doi-asserted-by":"crossref","unstructured":"Mac\u00edas Saint-Gerons D, Huerta \u00c1lvarez C, Garc\u00eda Poza P, Montero Corominas D, de la Fuente Honrubia C (2018) Trazodone utilization among the elderly in Spain. A population based study. Rev Psiquiatr Salud Ment. 11(4):208\u2010215.","DOI":"10.1016\/j.rpsm.2016.11.003"},{"issue":"5","key":"3133_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.semarthrit.2003.09.012","volume":"33","author":"JE Nord","year":"2004","unstructured":"Nord JE, Shah PK, Rinaldi RZ, Weisman MH (2004) Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: A report of 2 cases and review of the literature. Semin Arthritis Rheum 33(5):336\u2013351","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"3133_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2165\/11536390-000000000-00000","volume":"33","author":"S Olsson","year":"2010","unstructured":"Olsson S, Pal SN, Stergachis A, Couper M (2010) Pharmacovigilance activities in 55 low- and middle-income countries: A questionnaire-based analysis. Drug Saf 33(8):689\u2013703","journal-title":"Drug Saf"},{"issue":"1","key":"3133_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","volume":"16","author":"IL Haeusler","year":"2018","unstructured":"Haeusler IL, Chan XHS, Gu\u00e9rin PJ, White NJ (2018) The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: A systematic review. BMC Med 16(1):200","journal-title":"BMC Med"},{"issue":"12","key":"3133_CR47","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/15563650.2019.1677022","volume":"57","author":"DD Gummin","year":"2019","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ et al (2019) 2018 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila) 57(12):1220\u20131413","journal-title":"Clin Toxicol (Phila)"},{"key":"3133_CR48","doi-asserted-by":"crossref","unstructured":"Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C et al (2011) European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997\u20132009). J Antimicrob Chemother. 66 Suppl 6:vi37\u201345.","DOI":"10.1093\/jac\/dkr456"},{"issue":"1","key":"3133_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12879-018-3528-4","volume":"18","author":"MJ Day","year":"2018","unstructured":"Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ et al (2018) Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infect Dis 18(1):609","journal-title":"BMC Infect Dis"},{"issue":"Suppl 3","key":"3133_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1469-0691.2009.02725.x","volume":"15","author":"H Goossens","year":"2009","unstructured":"Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect 15(Suppl 3):12\u201315","journal-title":"Clin Microbiol Infect"},{"key":"3133_CR51","doi-asserted-by":"crossref","unstructured":"Hicks LA, Taylor TH Jr, Hunkler RJ (2013) U.S. outpatient antibiotic prescribing, 2010. N Engl J Med. 368(15):1461\u20132","DOI":"10.1056\/NEJMc1212055"},{"key":"3133_CR52","unstructured":"World Health Organization (WHO) (2018). WHO report on surveillance of antibiotic consumption: 2016\u20132018 early implementation. Geneva: World Health Organization. https:\/\/www.who.int\/medicines\/areas\/rational_use\/oms-amr-amc-report-2016-2018\/en\/ (accessed April, 2020)."},{"issue":"20","key":"3133_CR53","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM (2012) Azithromycin and the risk of cardiovascular death. N Engl J Med 366(20):1881\u20131890","journal-title":"N Engl J Med"},{"key":"3133_CR54","unstructured":"Food and Drug Administration (FDA) (2013) FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart (accessed June, 2020)."},{"issue":"7","key":"3133_CR55","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.1503\/cmaj.150901","volume":"188","author":"MH Trac","year":"2016","unstructured":"Trac MH, McArthur E, Jandoc R, Dixon SN, Nash DM, Hackam DG et al (2016) Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. CMAJ 188(7):E120\u2013E129","journal-title":"CMAJ"},{"issue":"15","key":"3133_CR56","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.1503\/cmaj.160355","volume":"189","author":"G Trifir\u00f2","year":"2017","unstructured":"Trifir\u00f2 G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S et al (2017) Use of azithromycin and risk of ventricular arrhythmia. CMAJ 189(15):E560\u2013E568","journal-title":"CMAJ"},{"issue":"10274","key":"3133_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group (2021) Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet 397(10274):605\u2013612","journal-title":"Lancet"},{"issue":"21","key":"3133_CR58","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A et al (2020) Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Engl J Med 383(21):2041\u20132052","journal-title":"N Engl J Med"},{"key":"3133_CR59","doi-asserted-by":"crossref","unstructured":"WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results (2021) N Engl J Med. 384(6):497\u2013511","DOI":"10.1056\/NEJMoa2023184"},{"issue":"12","key":"3133_CR60","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2471\/BLT.14.142570","volume":"92","author":"D Falzon","year":"2014","unstructured":"Falzon D, Hill G, Pal SN, Suwankesawong W, Jaramillo E (2014) Pharmacovigilance and tuberculosis: Applying the lessons of thioacetazone. Bull World Health Organ 92(12):918\u2013919","journal-title":"Bull World Health Organ"},{"issue":"4","key":"3133_CR61","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","volume":"3","author":"MGS Borba","year":"2020","unstructured":"Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mour\u00e3o MPG et al (2020) Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A randomized clinical trial. JAMA Netw Open 3(4):e208857","journal-title":"JAMA Netw Open"},{"key":"3133_CR62","doi-asserted-by":"crossref","unstructured":"Goldman SA (1998) Limitations and strengths of spontaneous reports data. Clin Ther 20 Suppl C:C40\u20134.","DOI":"10.1016\/S0149-2918(98)80007-6"},{"issue":"5","key":"3133_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","volume":"43","author":"O Caster","year":"2020","unstructured":"Caster O, Aoki Y, Gattepaille LM (2020) Grundmark B (2020) Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: Recommendations for Limiting False-Positive Associations. Drug Saf 43(5):479\u2013487","journal-title":"Drug Saf"},{"key":"3133_CR64","doi-asserted-by":"publisher","unstructured":"Sapp JL, Alqarawi W, MacIntyre CJ, Tadros R, Steinberg C, Roberts JD et al (2020) Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society. Can J Cardiol. 2020 Apr 8. pii: S0828\u2013282X(20)30325\u20131.\u00a0https:\/\/doi.org\/10.1016\/j.cjca.2020.04.003.","DOI":"10.1016\/j.cjca.2020.04.003"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03133-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:41:47Z","timestamp":1744087307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3133"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03133-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}